Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
NLS Pharmaceutics ( (NLSP) ) has provided an update.
On April 18, 2025, Audrey Greenberg resigned from the Board of Directors of NLS Pharmaceutics Ltd. as part of the company’s strategic efforts to reduce cash burn and align with the expected post-merger board composition. Her resignation was not due to any disagreements with the company’s operations or policies, and it reflects the company’s ongoing restructuring plans.
More about NLS Pharmaceutics
NLS Pharmaceutics Ltd. operates in the pharmaceutical industry, focusing on the development of innovative therapies for rare and complex central nervous system disorders. The company is based in Zurich, Switzerland, and is involved in efforts to optimize its operations and financial management.
YTD Price Performance: -32.57%
Average Trading Volume: 2,063,310
Technical Sentiment Signal: Buy
Current Market Cap: $3.54M
For an in-depth examination of NLSP stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue